financetom
Business
financetom
/
Business
/
Hewlett Packard Enterprise Insider Sold Shares Worth $616,173, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hewlett Packard Enterprise Insider Sold Shares Worth $616,173, According to a Recent SEC Filing
Jun 30, 2025 3:12 PM

05:42 PM EDT, 06/30/2025 (MT Newswires) -- Phil Mottram, EVP, GM, Intelligent Edge, on June 30, 2025, sold 30,000 shares in Hewlett Packard Enterprise ( HPE ) for $616,173. Following the Form 4 filing with the SEC, Mottram has control over a total of 42,427 shares of the company, with 42,427 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1645590/000106299325012298/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Duckhorn Shares Double After Fiscal Q4 Adjusted Earnings, Net Sales Beat Estimates
Duckhorn Shares Double After Fiscal Q4 Adjusted Earnings, Net Sales Beat Estimates
Oct 7, 2024
07:41 AM EDT, 10/07/2024 (MT Newswires) -- The Duckhorn Portfolio's ( NAPA ) shares were up more than 101% in Monday's premarket activity after it beat earnings and revenue expectations. The wine company reported fiscal Q4 adjusted net income Monday day of $0.14 per diluted share, down from $0.15 a year earlier. Analysts polled by Capital IQ expected $0.10. Net...
BRIEF-Bruker BioSpin Acquires Bridge12 EPR Business
BRIEF-Bruker BioSpin Acquires Bridge12 EPR Business
Oct 7, 2024
Oct 7 (Reuters) - Bruker Corp ( BRKR ): * BRUKER CORP ( BRKR ): BRUKER BIOSPIN ACQUIRES BRIDGE12 EPR BUSINESS Source text for Eikon: Further company coverage: ...
Scholar Rock's Phase 3 Apitegromab Trial for Patients With Spinal Muscular Atrophy Meets Primary Endpoint
Scholar Rock's Phase 3 Apitegromab Trial for Patients With Spinal Muscular Atrophy Meets Primary Endpoint
Oct 7, 2024
07:40 AM EDT, 10/07/2024 (MT Newswires) -- Scholar Rock Holding ( SRRK ) said Monday a phase 3 trial for its investigational therapy apitegromab met its primary endpoint. Patients with spinal muscular atrophy showed 'statistically significant and clinically meaningful improvement' in motor function after receiving apitegromab, Scholar Rock ( SRRK ) said. The company said it plans to submit a...
Foremost Clean Energy Completes Phase One of Denison Mines Deal
Foremost Clean Energy Completes Phase One of Denison Mines Deal
Oct 7, 2024
07:46 AM EDT, 10/07/2024 (MT Newswires) -- Foremost Clean Energy ( FMST ) said Monday it has completed phase one of its transaction with Denison Mines ( DNN ) , acquiring 20% of Denison's interest in 10 uranium exploration properties in northern Saskatchewan's Athabasca Basin and becoming the operator of the exploration properties. As part of the deal, Denison received...
Copyright 2023-2026 - www.financetom.com All Rights Reserved